---
archetype: bookmark
date: 2019-04-21T15:11:17Z
description: This Viewpoint discusses the inadequacy of hemoglobin A1c levels as a
  marker of effects of treatment on clinically important diabetes outcomes, and argues
  for replacing it with measures of treatment effects important to patients and their
  caregivers, such as hyperglycemia and hypoglycemia, vision.
dropmark.editURL: http://radhikan.dropmark.com/616548/18507640
featuredImage: /img/content/post/jamanetwork-measuring-what-matters-in-diabetes.jpg
link: https://jamanetwork.com/journals/jama/fullarticle/2730954
linkBrand: jamanetwork.com
slug: jamanetwork-measuring-what-matters-in-diabetes
socialScore: 42
socialScoreSimulated: true
source:
  name: Dropmark
  apiendpoint: https://shah.dropmark.com/616548.json
title: Measuring What Matters in Diabetes
---
This Viewpoint discusses the inadequacy of hemoglobin A1c levels as a marker of effects of treatment on clinically important diabetes outcomes, and argues for replacing it with measures of treatment effects important to patients and their caregivers, such as hyperglycemia and hypoglycemia, vision...